Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$11,986,002
-$2,006,746 QoQ
Shares Held
94,871
-5.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
2.91%
of 13F equity value
Holder Rank
#402
of 2,266 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kiltearn Partners LLP holds $11,986,002 across 1 Drug Manufacturers - General name. GILD ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
This page
|
94,871 | $11,986,002 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,986,002 | 94,871 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $13,992,748 | 100,400 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $14,888,362 | 121,300 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,183,800 | 145,800 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $14,900,928 | 134,400 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $16,359,300 | 146,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $13,938,633 | 150,900 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $6,086,784 | 72,600 | Shares | Sole | 2024-11-13 | |
| 2020-03-31 | $32,879,448 | 439,800 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||